ProQR Therapeutics (PRQR) Payables (2013 - 2025)
ProQR Therapeutics recorded quarterly Payables of $346885.0 in Q4 2025, up 1928.86% quarter-over-quarter from $17097.5 in Q4 2024, and up 1928.86% year-over-year from $17097.5 in Q4 2024.
ProQR Therapeutics' Payables history runs 13 years deep, the most recent figure standing at $346885.0 for Q4 2025.
- In Q4 2025, Payables rose 1928.86% year-over-year to $346885.0; the TTM figure through Dec 2025 stood at $346885.0 (up 1928.86% YoY), while the FY2025 annual figure was $346885.0, up 1928.86% from the prior year.
- Payables came in at $346885.0 for Q4 2025 at ProQR Therapeutics, up from $17097.5 in the prior quarter.
- In the past five years, Payables ranged from a high of $21.5 billion in Q1 2021 to a low of $17097.5 in Q4 2024.
- A 5-year average of $1.5 billion and a median of $414226.8 in 2022 frame the typical range for Payables.
- Across the five-year window, Payables jumped 3372984.98% in 2021 and sank 100.0% in 2022, its largest moves.
- ProQR Therapeutics' Payables stood at $5.7 million in 2021, then slumped by 92.95% to $399937.0 in 2022, then soared by 314.57% to $1.7 million in 2023, then sank by 98.97% to $17097.5 in 2024, then soared by 1928.86% to $346885.0 in 2025.
- According to Business Quant data, Payables over the past three periods registered $346885.0, $17097.5, and $1.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 346,884.97 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 346,884.97 |
| Dec 31, 2024 | 17,097.53 |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 127,365.09 |
| Jun 30, 2023 | 129,582.00 |
| Mar 31, 2023 | 296,242.34 |
| Dec 31, 2022 | 399,936.97 |
| Sep 30, 2022 | 428,516.59 |
| Jun 30, 2022 | 818,432.48 |
| Mar 31, 2022 | 924,806.28 |
| Dec 31, 2021 | 5.68 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 332,378.92 |
| Mar 31, 2021 | 21.52 Bn |
| Dec 31, 2020 | 1.62 Mn |
| Sep 30, 2020 | 339,910.48 |
| Jun 30, 2020 | 541,918.38 |
| Mar 31, 2020 | 638,076.76 |
| Dec 31, 2019 | 872,227.49 |
| Sep 30, 2019 | 743,303.66 |
| Jun 30, 2019 | 211,244.15 |
| Mar 31, 2019 | 72.74 |
| Dec 31, 2018 | 154,088.52 |
| Sep 30, 2018 | 896.77 |
| Jun 30, 2018 | 261,364.33 |
| Mar 31, 2018 | 180.59 |
| Dec 31, 2017 | 2.95 Mn |
| Dec 31, 2016 | 354,149.54 |
| Sep 30, 2016 | 264.54 |
| Dec 31, 2015 | 970.06 |
| Mar 31, 2015 | 2.73 Mn |
| Dec 31, 2014 | 1.56 Mn |
| Sep 30, 2014 | 1.46 Mn |
| Dec 31, 2013 | 1.01 Mn |